Solid Biosciences (SLDB) Other Non Operating Income (2017 - 2026)
Solid Biosciences (SLDB) reported Other Non Operating Income of -$1.6 million for Q1 2026, little changed on a YoY basis from -$1.6 million in Q1 2025, and down 853.42% sequentially from $219000.0 in Q4 2025.
Solid Biosciences (SLDB) Other Non Operating Income (2017 - 2026) Analysis & Trends
Solid Biosciences (SLDB) has 10 years of Other Non Operating Income data on file, last reported at -$1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income changed 0.0% year-over-year to -$1.6 million; the trailing twelve-month figure through Mar 2026 stood at -$2.1 million (down 107.19% YoY), and the FY2025 full-year result was $824000.0, up 26.38% from the prior year.
- Other Non Operating Income declined to -$1.6 million in Q1 2026, from $219000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $282000.0 in Q1 2023 to a low of -$1.6 million in Q1 2025.
- A 5-year average of -$138705.9 and a median of $199000.0 in 2024 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income jumped 8933.33% in 2023 and plunged 55100.0% in 2025, its largest moves.
- Tracing SLDB's Other Non Operating Income over 5 years: stood at -$355000.0 in 2022, then soared by 176.06% to $270000.0 in 2023, then fell by 26.3% to $199000.0 in 2024, then advanced by 10.05% to $219000.0 in 2025, then sank by 853.42% to -$1.6 million in 2026.
- Business Quant data shows SLDB's Other Non Operating Income at -$1.6 million in Q1 2026, $219000.0 in Q4 2025, and -$850000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Solid Biosciences | 529.40 Mn | 529.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.65 Mn |
| Dec 31, 2025 | 219,000.00 |
| Sep 30, 2025 | -850,000.00 |
| Jun 30, 2025 | 207,000.00 |
| Mar 31, 2025 | -1.65 Mn |
| Dec 31, 2024 | 199,000.00 |
| Sep 30, 2024 | 211,000.00 |
| Jun 30, 2024 | 239,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 270,000.00 |
| Sep 30, 2023 | 278,000.00 |
| Jun 30, 2023 | 265,000.00 |
| Mar 31, 2023 | 282,000.00 |
| Dec 31, 2022 | -355,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Jun 30, 2022 | -3,000.00 |
| Mar 31, 2022 | -10,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2020 | 1,000.00 |
| Dec 31, 2019 | 170,000.00 |